Novo Nordisk Could Win the Oral GLP-1 Race Against Lilly. Why It Just Raised Guidance. – Barron’s

Novo Nordisk stock rose as it raised its guidance on the back of the strong performance of its weight-loss pill.

#stockmarket #breaking

Leave a Reply

WP Twitter Auto Publish Powered By : XYZScripts.com